default author photo

Carol Ho-Yan Fong

The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

537

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines

Number of pages: 36 Posted: 08 Feb 2022
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Li Ka Shing Faculty of Medicine, Princess Margaret Hospital - Department of Medicine, The University of Hong Kong, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Southern Medical University - Division of Laboratory Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 421 (172,704)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, Neutralizing antibody, Surrogate neutralizing antibody test, spike protein receptor binding domain, Variants of Concern

2.

Effect of Vaccine Booster, Vaccine Type, and Hybrid Immunity on Humoral and Cellular Immunity Against SARS-CoV-2 Ancestral Strain and Omicron Variant Sublineages BA.2 and BA.5 Among Older Adults with Comorbidities: An Observational Study

Number of pages: 29 Posted: 14 Sep 2022
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Department of Family Medicine and Primary Care, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine, The University of Hong Kong - Division of Geriatrics and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 116 (613,149)

Abstract:

Loading...

COVID-19, SARS-CoV-2, older adults, vaccine booster, neutralizing antibody, T cell response, hybrid immunity